These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33435264)

  • 1. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B.
    Ottanà R; Paoli P; Cappiello M; Nguyen TN; Adornato I; Del Corso A; Genovese M; Nesi I; Moschini R; Naß A; Wolber G; Maccari R
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
    Maccari R; Del Corso A; Paoli P; Adornato I; Lori G; Balestri F; Cappiello M; Naß A; Wolber G; Ottanà R
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3712-3720. PubMed ID: 30342956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
    Kousaxidis A; Petrou A; Lavrentaki V; Fesatidou M; Nicolaou I; Geronikaki A
    Eur J Med Chem; 2020 Dec; 207():112742. PubMed ID: 32871344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.
    Genovese M; Imperatore C; Casertano M; Aiello A; Balestri F; Piazza L; Menna M; Del Corso A; Paoli P
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors.
    Maccari R; Wolber G; Genovese M; Sardelli G; Talagayev V; Balestri F; Luti S; Santi A; Moschini R; Del Corso A; Paoli P; Ottanà R
    Eur J Med Chem; 2023 Apr; 252():115270. PubMed ID: 36934484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory activity of Aralia continentalis roots on protein tyrosine phosphatase 1B and rat lens aldose reductase.
    Jung HJ; Jung HA; Kang SS; Lee JH; Cho YS; Moon KH; Choi JS
    Arch Pharm Res; 2012 Oct; 35(10):1771-7. PubMed ID: 23139128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.
    Patel AD; Barot R; Parmar I; Panchal I; Shah U; Patel M; Mishtry B
    Curr Comput Aided Drug Des; 2018; 14(4):349-362. PubMed ID: 29701158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
    Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
    Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
    Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and
    Yang L; Chen F; Gao C; Chen J; Li J; Liu S; Zhang Y; Wang Z; Qian S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):152-164. PubMed ID: 31742469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase and protein tyrosine phosphatase 1B inhibitory active compounds from Syzygium cumini seeds.
    Sawant L; Singh VK; Dethe S; Bhaskar A; Balachandran J; Mundkinajeddu D; Agarwal A
    Pharm Biol; 2015 Aug; 53(8):1176-82. PubMed ID: 25853967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.